Published in Cytogenet Cell Genet on January 01, 1993
Cyanine dye dUTP analogs for enzymatic labeling of DNA probes. Nucleic Acids Res (1994) 1.09
Differentially painting human chromosome arms with combined binary ratio-labeling fluorescence in situ hybridization. Genome Res (2000) 0.84
Behavior of DNA fibers stretched by precise meniscus motion control. Nucleic Acids Res (2001) 0.80
Nonradioactive In Situ Hybridization: Recent Techniques and Applications. Endocr Pathol (1998) 0.79
A modified protocol for the detection of three different mRNAs with a new-generation in situ hybridization chain reaction on frozen sections. J Mol Histol (2016) 0.75
Heterogeneity in telomere length of human chromosomes. Hum Mol Genet (1996) 6.55
Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci U S A (1997) 4.88
Photobleaching kinetics of fluorescein in quantitative fluorescence microscopy. Biophys J (1995) 3.08
Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J Biol Chem (1989) 2.91
Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation (1989) 2.67
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry (1988) 2.26
D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene (1991) 2.21
Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. Genomics (2000) 2.16
Influence of the triplet excited state on the photobleaching kinetics of fluorescein in microscopy. Biophys J (1996) 2.11
Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fluorochrome tyramides. Hum Mol Genet (1995) 2.07
Linear 2' O-Methyl RNA probes for the visualization of RNA in living cells. Nucleic Acids Res (2001) 2.03
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain (2003) 1.82
Association of alpha- and beta-subunits during the biosynthesis of beta-hexosaminidase in cultured human fibroblasts. J Biol Chem (1984) 1.75
Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell (1988) 1.73
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.72
Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood (1995) 1.71
Fluorochrome-labeled tyramides: use in immunocytochemistry and fluorescence in situ hybridization. J Histochem Cytochem (1997) 1.71
Up-converting phosphor reporters for nucleic acid microarrays. Nat Biotechnol (2001) 1.65
Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood (1998) 1.63
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia (2012) 1.60
Mutational analysis of fibrillarin and its mobility in living human cells. J Cell Biol (2000) 1.57
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet (1990) 1.52
Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol (2011) 1.48
Correlations between isochores and chromosomal bands in the human genome. Proc Natl Acad Sci U S A (1993) 1.45
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial. Eur J Cancer (1999) 1.44
Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4 Eo. Hum Mol Genet (1993) 1.40
Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev (1996) 1.39
Methods for visualizing RNA processing and transport pathways in living cells. Histochem Cell Biol (2001) 1.38
Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev (1995) 1.37
Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood (1995) 1.34
Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation (1984) 1.32
High-resolution in situ hybridization using DNA halo preparations. Hum Mol Genet (1992) 1.31
Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J Biol Chem (1991) 1.30
A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer (2012) 1.28
Characterization and chromosomal localization of the human proto-oncogene BMI-1. Hum Mol Genet (1993) 1.28
Interphase cytogenetics of brain tumors. Genes Chromosomes Cancer (1991) 1.28
Infrared up-converting phosphors for bioassays. IEE Proc Nanobiotechnol (2005) 1.27
A homozygous deletion of a normal variation locus in a patient with hearing loss from non-consanguineous parents. J Med Genet (2009) 1.26
Spreading and staining of human metaphase chromosomes on aminoalkylsilane-treated glass slides. Histochem J (1982) 1.26
T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies. J Immunol (1981) 1.26
Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase. Hum Mol Genet (1997) 1.24
Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood (2000) 1.24
Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene (1996) 1.24
Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur J Hum Genet (1994) 1.23
Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate-early gene products by protein synthesis inhibition. J Virol (1986) 1.23
Multiple fluorescence in situ hybridization. Cytometry (1990) 1.22
Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction. J Virol Methods (1989) 1.22
Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol (1996) 1.21
Subnuclear localization of the active variant surface glycoprotein gene expression site in Trypanosoma brucei. Proc Natl Acad Sci U S A (1998) 1.20
Identification of genetic markers for prostatic cancer progression. Lab Invest (2000) 1.19
New strategy for multi-colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling. Eur J Hum Genet (1999) 1.19
Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia (1997) 1.19
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer (1998) 1.19
Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res (1999) 1.18
The glial and mesenchymal elements of gliosarcomas share similar genetic alterations. J Neuropathol Exp Neurol (1996) 1.17
ULS: a versatile method of labeling nucleic acids for FISH based on a monofunctional reaction of cisplatin derivatives with guanine moieties. Cytogenet Cell Genet (1999) 1.16
Genetic heterogeneity in human neuraminidase deficiency. Nature (1980) 1.16
Chromosome studies in 1792 males prior to intra-cytoplasmic sperm injection: the Dutch experience. Eur J Hum Genet (1998) 1.16
Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia (2006) 1.16
A male infant with holoprosencephaly, associated with ring chromosome 21. Clin Genet (1987) 1.15
Universal linkage system: an improved method for labeling archival DNA for comparative genomic hybridization. Genes Chromosomes Cancer (1999) 1.13
Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Hum Mol Genet (2000) 1.13
Analysis of antifading reagents for fluorescence microscopy. Cytometry (1995) 1.13
Faulty association of alpha- and beta-subunits in some forms of beta-hexosaminidase A deficiency. J Biol Chem (1984) 1.12
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features. Am J Pathol (2001) 1.11
Fluorescence in situ hybridization using horseradish peroxidase-labeled oligodeoxynucleotides and tyramide signal amplification for sensitive DNA and mRNA detection. Histochem Cell Biol (1998) 1.11
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways. J Pathol (2008) 1.11
Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. Pharmacogenetics (1999) 1.11
Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.10
New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy. J Biol Inorg Chem (2000) 1.10
Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A. EMBO J (1998) 1.10
In situ hybridization with fluoresceinated DNA. Nucleic Acids Res (1991) 1.09
Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism. Structure (1995) 1.09
Workshop on inborn errors of metabolism. Prog Clin Biol Res (1982) 1.09
Mouse "protective protein". cDNA cloning, sequence comparison, and expression. J Biol Chem (1990) 1.09
Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation. Mol Cell Biol (1998) 1.09
Sensitive mRNA detection by fluorescence in situ hybridization using horseradish peroxidase-labeled oligodeoxynucleotides and tyramide signal amplification. J Histochem Cytochem (1998) 1.09
Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood (2000) 1.09
Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene (1995) 1.07
Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Genes Chromosomes Cancer (2001) 1.07
Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Res (1993) 1.07
Clonal analysis of a case of multifocal oesophageal (Barrett's) adenocarcinoma by comparative genomic hybridization. J Pathol (1999) 1.07